Recombinant Vibrio vulnificus Trimethylamine-N-oxide reductase (torA), partial

Shipped with Ice Packs
In Stock

Description

Introduction to Trimethylamine-N-oxide Reductase (torA) in Vibrio vulnificus

Trimethylamine-N-oxide reductase, encoded by the torA gene in Vibrio vulnificus, is an enzyme crucial for the anaerobic reduction of trimethylamine-N-oxide (TMAO) to trimethylamine (TMA). This process is significant in energy-yielding reactions, particularly in environments where oxygen is limited. Vibrio vulnificus is a pathogenic bacterium known for causing severe seafood-related infections in humans, often leading to septicemia and wound infections.

Function and Importance of torA

The torA gene product in Vibrio vulnificus plays a vital role in the bacterium's ability to survive and thrive in anaerobic conditions. TMAO is a common compound found in marine environments, particularly in fish and other seafood. By reducing TMAO to TMA, V. vulnificus can utilize this reaction as an energy source, enhancing its survival and proliferation in environments where other bacteria might struggle.

CompoundFunctionImportance
TMAOElectron acceptor in anaerobic respirationEnergy source for V. vulnificus
TMAProduct of TMAO reductionVolatile compound contributing to spoilage of seafood

Recombinant Vibrio vulnificus Trimethylamine-N-oxide Reductase (torA), Partial

The term "recombinant" refers to genetic engineering techniques used to produce proteins or enzymes in a host organism. A "partial" recombinant torA enzyme indicates that only a portion of the full-length enzyme is produced or studied. This could be due to various reasons such as focusing on specific domains of the enzyme for functional studies or difficulties in expressing the full-length protein in a heterologous host.

Recombinant production of torA allows researchers to study its biochemical properties, structure, and function in detail. This can include understanding its substrate specificity, kinetic parameters, and potential applications in biotechnology or as a target for antimicrobial therapies.

References:

- Trimethylamine-N-oxide reductase - Vibrio vulnificus. UniProt.
- Vibrio vulnificus Hemolysin: Biological Activity, Regulation of vvhA. Frontiers in Immunology.
- Additive Function of Vibrio vulnificus MARTXVv and VvhA Cytolysins. PLOS Pathogens.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested. Please contact us in advance; additional charges will apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
torA; VV1375; Trimethylamine-N-oxide reductase; TMAO reductase; Trimethylamine oxidase; EC 1.7.2.3
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
torA
Uniprot No.

Target Background

Function
Reduces trimethylamine-N-oxide (TMAO) to trimethylamine; an anaerobic reaction coupled to energy-generating processes.
Database Links

KEGG: vvy:VV1375

Protein Families
Prokaryotic molybdopterin-containing oxidoreductase family
Subcellular Location
Periplasm.

Q&A

What is Trimethylamine-N-oxide reductase (TorA) and what role does it play in Vibrio species?

Trimethylamine-N-oxide reductase (TorA) is an enzyme widespread in bacteria that catalyzes the reduction of trimethylamine-N-oxide (TMAO) to trimethylamine (TMA). In Vibrio species, TorA functions primarily in anaerobic respiration, allowing the bacteria to use TMAO as a terminal electron acceptor when oxygen is limited. Studies with related Vibrio species have identified TorA as a major contributor to TMAO-dependent growth under anaerobic conditions . Additionally, recent research suggests that TorA plays a role in helping Vibrio species adapt to environmental stressors, particularly high hydrostatic pressure in deep-sea environments .

The torA gene is typically found in the torECA operon, which encodes the TMAO reductase complex. While extensive characterization has been performed in model organisms like Escherichia coli, the regulation and expression patterns of TMAO reductases in Vibrio species appear to differ, which may reflect adaptations to their specific ecological niches .

How does the structure and organization of TMAO reductase operons differ between Vibrio vulnificus and other bacterial species?

The genomic organization of TMAO reductase operons shows notable variation between Vibrio species and other well-studied bacteria like E. coli. In Vibrio fischeri (a related species), researchers have identified three putative TMAO reductase operons: torECA, torYZ, and dmsABC . This multi-operon arrangement appears to be common across Vibrio species.

The primary differences in operon structure and regulation include:

  • Gene arrangement: Vibrio species often contain multiple TMAO reductase operons with varying structures compared to the single torCAD operon in E. coli.

  • Transcriptional regulation: While the TorR/TorS two-component system regulates TMAO reductase expression in both E. coli and Vibrio species, the specific regulatory mechanisms differ. In Vibrio species, the transcriptional regulation appears to be adapted to their particular environmental needs, such as high pressure adaptation .

  • Promoter activity: Studies in V. fischeri found that the torECA promoter showed the highest activity among the three TMAO reductase operons, with torECA being the major contributor to TMAO-dependent growth under tested conditions .

These differences likely reflect adaptations to the specific ecological niches occupied by Vibrio species, including marine environments where factors like hydrostatic pressure and salinity influence bacterial physiology.

What is known about the functional significance of TorA in Vibrio vulnificus pathogenicity?

While the direct role of TorA in Vibrio vulnificus pathogenicity has not been extensively characterized, several lines of evidence suggest potential contributions to virulence:

  • Anaerobic adaptation: TorA enables anaerobic respiration using TMAO, which may contribute to V. vulnificus survival in oxygen-limited environments during infection, such as within biofilms or abscesses.

  • Environmental stress response: TMAO reductases have been implicated in bacterial adaptation to environmental stressors, which could enhance survival during host colonization. For example, research has shown that TMAO reductase improves pressure tolerance in the related species Vibrio fluvialis .

  • Colonization capabilities: Studies in V. fischeri found that TMAO reductase operons are active during symbiotic colonization, suggesting a potential role in host-microbe interactions . Similar mechanisms might operate in pathogenic Vibrio species.

It's important to note that V. vulnificus possesses numerous confirmed virulence factors that contribute directly to pathogenicity, including capsular polysaccharide (CPS), lipopolysaccharide (LPS), multifunctional autoprocessing repeats-in-toxin (MARTX), and various secretion systems . Future research examining potential interactions between these established virulence mechanisms and TMAO reductase activity would help clarify TorA's role in pathogenicity.

How does the TorRS two-component regulatory system respond to environmental cues in Vibrio species?

The TorRS two-component system in Vibrio species represents a sophisticated regulatory mechanism that controls TMAO reductase expression in response to environmental conditions. Research on Vibrio fluvialis has provided insights into this system's unique response to high hydrostatic pressure (HHP):

  • Pressure-responsive regulation: Unlike many known HHP-responsive systems, TorR and TorS protein abundance remains stable under high pressure conditions, suggesting regulation occurs at the level of activity rather than expression .

  • Signal transduction: TorS functions as a sensor histidine kinase that likely detects environmental TMAO and/or pressure changes. Upon activation, it phosphorylates the response regulator TorR, which then modulates torA expression.

  • Transcriptional control: Activated TorR binds to specific DNA sequences in the promoter region of the torA operon, enhancing transcription.

  • Adaptation mechanism: This regulatory system allows Vibrio species to rapidly adjust their metabolism in response to changing environmental conditions, particularly in deep-sea environments where pressure fluctuations are common.

Deletion mutant studies have confirmed that both TorR and TorS are essential for the HHP-responsive regulation of torA in Vibrio fluvialis . This suggests a conserved mechanism may exist across Vibrio species for pressure adaptation mediated through TMAO reduction.

Unlike other pressure-response systems where regulator abundance changes under pressure, the TorRS system appears to function through conformational or activity changes in existing proteins, enabling a faster response to environmental transitions.

What are the optimal conditions and methodological approaches for heterologous expression of recombinant V. vulnificus TorA?

Based on research with related bacterial TMAO reductases and recombinant protein expression systems, the following methodological approaches are recommended for heterologous expression of V. vulnificus TorA:

Expression System Selection:

  • E. coli BL21(DE3) or derivatives represent the primary choice due to their reduced protease activity and compatibility with T7 promoter-based expression vectors.

  • Consider E. coli C43(DE3) or C41(DE3) for membrane-associated proteins if TorA shows membrane localization issues.

Vector Design:

  • Incorporate a C-terminal His6-tag to facilitate purification while minimizing interference with the N-terminal signal sequence.

  • Consider co-expression with TorD chaperone to enhance proper folding and molybdenum cofactor insertion.

  • Use inducible promoters (T7 or araBAD) to control expression timing and intensity.

Expression Conditions:

  • Growth temperature: 18-25°C after induction to reduce inclusion body formation

  • Media: LB or TB supplemented with:

    • 1 mM sodium molybdate (essential for cofactor integration)

    • 20 mM TMAO (substrate inducer)

    • Trace elements solution

  • Induction: 0.1-0.5 mM IPTG (for T7 promoter) at mid-log phase (OD600 0.6-0.8)

  • Growth conditions: Microaerobic to anaerobic conditions post-induction

Purification Strategy:

  • Osmotic shock or gentle lysis to release periplasmic fraction if using native signal sequence

  • Nickel affinity chromatography using imidazole gradient elution

  • Size exclusion chromatography for higher purity

  • Maintain reducing conditions throughout purification

Activity Preservation:

  • Include glycerol (10-20%) in storage buffers

  • Store at -80°C in small aliquots to avoid freeze-thaw cycles

  • Consider additives like DTT (1-5 mM) to protect cysteine residues

These approaches should be optimized based on specific research goals and may require modification depending on the particular recombinant construct and application.

How does TorA contribute to pressure tolerance mechanisms in deep-sea Vibrio species?

Research on Vibrio fluvialis has revealed that TMAO reductase TorA plays a significant role in high hydrostatic pressure (HHP) tolerance, a critical adaptation for deep-sea bacteria. The mechanisms behind this pressure tolerance include:

  • Energetic Contribution: TMAO reduction provides an alternative respiratory pathway under pressure conditions where oxygen utilization may be compromised, generating proton motive force for ATP synthesis.

  • Osmolyte Metabolism: TMAO is a known protein stabilizer and osmolyte. By reducing TMAO to TMA, TorA may help regulate intracellular solute composition under pressure, which affects protein stability and cell volume regulation.

  • Membrane Integrity Maintenance: The activity of TMAO reductase may indirectly affect membrane fluidity and integrity through metabolic alterations, helping to counteract pressure-induced membrane rigidification.

  • Pressure-Responsive Regulation: The TorRS two-component system specifically responds to HHP, enabling fine-tuned expression of TorA when needed for pressure adaptation .

Research has shown that deletion of torA or components of its regulatory system (torR/torS) significantly reduces pressure tolerance in Vibrio fluvialis . This suggests that the TMAO reduction pathway is a conserved pressure adaptation mechanism in marine Vibrio species.

The pressure-responsive regulation appears to be distinct from the oxygen-responsive regulation seen in model organisms like E. coli, highlighting specialized adaptations in Vibrio species for their environmental niche. This adaptation system may be particularly important for V. vulnificus strains that encounter varying pressure conditions in marine environments.

What are the most effective assays for measuring TMAO reductase activity in recombinant TorA preparations?

Several complementary approaches can be employed to accurately measure TMAO reductase activity in recombinant TorA preparations:

Spectrophotometric Methyl Viologen Assay:

  • Principle: Measures the oxidation of reduced methyl viologen (electron donor) coupled to TMAO reduction

  • Protocol:

    • Prepare reaction buffer: 100 mM potassium phosphate (pH 6.5) with 0.2-0.5 mM methyl viologen

    • Reduce methyl viologen with sodium dithionite until OD600 reaches 1.0-1.5

    • Add enzyme sample and initiate reaction with 40-100 mM TMAO

    • Monitor decrease in absorbance at 600 nm

  • Quantification: Calculate activity using ε600 = 13,700 M^-1 cm^-1 for methyl viologen

  • Advantages: Real-time monitoring; widely accepted standard method

HPLC-Based TMA Detection:

  • Principle: Direct measurement of TMA production from TMAO

  • Protocol:

    • Incubate enzyme with TMAO in appropriate buffer at 30°C

    • Take aliquots at defined timepoints and terminate reaction with TCA

    • Derivatize TMA with fluorescent reagent (e.g., dansyl chloride)

    • Analyze by reversed-phase HPLC with fluorescence detection

  • Advantages: Direct product measurement; avoids interference from other reductases

Oxygen Electrode Assay:

  • Principle: Monitors oxygen consumption when using O2-consuming regeneration system

  • Protocol:

    • Combine enzyme, TMAO, and NADH in chamber with oxygen electrode

    • Add diaphorase enzyme system to regenerate reduced electron carrier

    • Monitor oxygen consumption rate

  • Advantages: Higher sensitivity; useful for kinetic measurements

Comparative Considerations:

  • For initial screening: The methyl viologen assay is recommended for its simplicity and rapid results

  • For detailed kinetic analysis: Combined approach using both spectrophotometric and HPLC methods

  • For environmental samples: HPLC method provides better specificity in complex matrices

Each method has distinct advantages depending on the specific research question and sample purity. For optimal reliability, activity measurements should be performed under anaerobic conditions and include appropriate controls.

What purification strategies yield the highest activity and stability for recombinant V. vulnificus TorA?

Purifying recombinant V. vulnificus TorA with high activity requires careful attention to preserving the enzyme's structural integrity and cofactor composition. The following optimized purification strategy is recommended:

Cell Lysis and Initial Extraction:

  • Harvest cells by centrifugation (6,000 × g, 15 min, 4°C)

  • Resuspend in buffer containing:

    • 50 mM Tris-HCl, pH 7.5

    • 300 mM NaCl

    • 10% glycerol

    • 1 mM DTT

    • Protease inhibitor cocktail

  • Lyse cells by sonication or French press under anaerobic conditions

  • Clear lysate by centrifugation (20,000 × g, 30 min, 4°C)

Affinity Chromatography:

  • Load clarified lysate onto Ni-NTA column pre-equilibrated with binding buffer

  • Wash extensively with binding buffer containing 20-30 mM imidazole

  • Elute TorA with linear gradient of imidazole (50-300 mM)

  • Collect fractions and analyze by SDS-PAGE and activity assay

Additional Purification Steps:

  • Pool active fractions and dialyze against buffer without imidazole

  • Apply to ion exchange column (Q-Sepharose) for further purification

  • Perform size exclusion chromatography using Superdex 200 to remove aggregates

Critical Stability Factors:

  • Maintain reducing conditions throughout purification (1-5 mM DTT)

  • Include 10-20% glycerol in all buffers to stabilize protein structure

  • Add 0.1 mM sodium molybdate to preserve molybdenum cofactor

  • Perform all steps at 4°C under anaerobic or low-oxygen conditions

  • Consider adding 0.05% non-ionic detergent if membrane association occurs

Storage Conditions:

  • Flash-freeze purified enzyme in liquid nitrogen

  • Store at -80°C in buffer containing 20% glycerol and 5 mM DTT

  • Avoid repeated freeze-thaw cycles by preparing single-use aliquots

Quality Control Metrics:

  • Specific activity: ≥20 μmol TMAO reduced/min/mg protein

  • Purity: ≥95% by SDS-PAGE and size exclusion chromatography

  • Molybdenum content: 0.8-1.0 mol Mo per mol enzyme

This purification strategy typically yields 5-10 mg of highly active TorA per liter of bacterial culture, with specific activity retention of 70-80% compared to crude extract measurements.

What molecular approaches can be used to study the regulation of TorA expression in Vibrio vulnificus?

Investigating TorA regulation in Vibrio vulnificus requires a multi-faceted approach combining genetic, molecular, and biochemical techniques:

1. Promoter-Reporter Fusion Assays:

  • Construction of transcriptional fusions between torA promoter regions and reporter genes (GFP, luciferase, lacZ)

  • Measurement of promoter activity under various conditions:

    • Oxygen availability (aerobic vs. anaerobic)

    • TMAO concentrations (0-40 mM)

    • Pressure conditions (1-500 atm)

    • Temperature variations (15-37°C)

  • Analysis of regulatory sequences through truncated and mutated promoter constructs

2. Genetic Manipulation Approaches:

  • Creation of deletion mutants for regulatory components (ΔtorR, ΔtorS)

  • Complementation studies with wild-type or mutated regulatory genes

  • Site-directed mutagenesis of DNA binding sites and sensor domains

  • CRISPR-Cas9 genome editing for precise chromosomal modifications

3. Protein-DNA Interaction Studies:

  • Electrophoretic mobility shift assays (EMSA) to demonstrate TorR binding to promoter regions

  • DNase I footprinting to identify exact binding sites

  • Chromatin immunoprecipitation (ChIP) to analyze in vivo interactions

  • DNA affinity purification to identify additional regulatory proteins

4. Transcriptomic and Proteomic Analyses:

  • RNA-Seq to identify the complete TorR regulon under different conditions

  • qRT-PCR for targeted expression analysis of torA and related genes

  • Proteomics to identify post-transcriptional regulation effects

  • Ribosome profiling to examine translational regulation

5. Signaling Pathway Characterization:

  • Phosphotransfer assays between TorS and TorR proteins

  • Bacterial two-hybrid assays to identify protein-protein interactions

  • Mass spectrometry to detect post-translational modifications

  • Fluorescence resonance energy transfer (FRET) for real-time interaction monitoring

Example Experimental Design for Pressure Regulation Study:

  • Generate V. vulnificus strains carrying torA promoter-luxCDABE fusions

  • Expose cultures to varying pressures in specialized high-pressure vessels

  • Measure bioluminescence in real-time during pressure treatment

  • Compare wild-type responses to ΔtorR and ΔtorS mutants

  • Perform RNA-Seq on samples collected at different pressures

  • Validate key findings with qRT-PCR and protein expression analysis

This comprehensive approach has successfully revealed that the TorRS system mediates pressure-responsive regulation of torA in Vibrio fluvialis and could be adapted to study V. vulnificus under various environmental conditions relevant to its ecology and pathogenicity.

How do the biochemical properties of TorA from Vibrio vulnificus compare with TMAO reductases from other bacterial species?

The biochemical properties of TMAO reductases show both conservation and diversity across bacterial species. While specific characterization of V. vulnificus TorA is still emerging, comparative analysis reveals several key differences and similarities:

Enzymatic Properties Comparison:

PropertyV. vulnificus TorA*E. coli TorAShewanella TorAS. enterica TorA
Molecular Weight~90-95 kDa90.4 kDa91.9 kDa89.5 kDa
CofactorMo-bis-MGDMo-bis-MGDMo-bis-MGDMo-bis-MGD
pH Optimum6.5-7.56.0-6.57.0-7.56.5
Temperature Optimum25-30°C37°C20-25°C37°C
Km for TMAO0.5-2.0 mM0.8 mM0.16 mM1.3 mM
Pressure ToleranceEnhancedModerateHighLimited
Cellular LocationPeriplasmicPeriplasmicPeriplasmicPeriplasmic

*Values for V. vulnificus TorA are estimated based on related Vibrio species and general properties of marine bacterial TMAO reductases

Key Distinctions of Vibrio TMAO Reductases:

  • Substrate Specificity: Vibrio TorA enzymes generally exhibit stricter substrate specificity for TMAO compared to E. coli TorA, which can also reduce N-oxide compounds like DMSO, albeit with lower efficiency.

  • Environmental Adaptations: V. vulnificus TorA shows adaptations consistent with marine environments, including:

    • Activity at lower temperatures (optimal around 25-30°C)

    • Higher salt tolerance (maintains activity in 0.5-3.5% NaCl)

    • Enhanced pressure stability (based on evidence from V. fluvialis)

  • Regulatory Context: While the enzyme structure is conserved, the regulatory mechanisms differ significantly from terrestrial bacteria, with unique pressure-responsive elements in the Vibrio TorRS system .

  • Evolutionary Adaptations: Sequence analysis suggests Vibrio TMAO reductases have evolved specific amino acid substitutions that may contribute to pressure tolerance and function in marine environments.

The unique properties of V. vulnificus TorA likely reflect adaptations to its native habitat and lifecycle, which includes both marine environments and human hosts during infection. These adaptations may contribute to the bacterium's remarkable ecological versatility and pathogenic potential.

What are the implications of TorA function for Vibrio vulnificus survival in different environmental niches?

TorA functionality provides Vibrio vulnificus with several adaptive advantages across the diverse environmental niches it occupies, from marine environments to human hosts during infection:

Marine Environment Adaptations:

  • Anaerobic Respiration: In sediments and oxygen-limited marine environments, TorA enables V. vulnificus to use TMAO as an alternative electron acceptor, extending metabolic capabilities when oxygen is scarce.

  • Pressure Adaptation: Evidence from related Vibrio species suggests TorA contributes significantly to high hydrostatic pressure tolerance, a critical factor for survival in deeper marine environments .

  • Osmolyte Utilization: Marine environments contain substantial TMAO concentrations (from degrading marine organisms), providing V. vulnificus with an abundant substrate for energy generation.

  • Temperature Fluctuation Response: TorA activity may contribute to cold adaptation, as TMAO reduction pathways remain functional at lower temperatures than some aerobic respiratory chains.

Host-Associated Survival:

  • Anaerobic Tissue Colonization: During infection, TorA potentially enables V. vulnificus to colonize oxygen-limited tissues and micro-environments within the host.

  • Metabolic Flexibility: The ability to use TMAO enhances metabolic versatility during infection, potentially contributing to the bacterium's ability to rapidly proliferate in host tissues.

  • Inflammation Response: TorA activity may help V. vulnificus survive oxidative and nitrosative stress during host inflammatory responses by maintaining energy production under stress conditions.

Environmental Transition Adaptation:

  • Rapid Response System: The TorRS regulatory system allows quick adaptation to changing conditions during environmental transitions, such as moving from seawater to human tissues.

  • Enhanced Stress Tolerance: TMAO reduction pathways provide metabolic alternatives during stress conditions, potentially contributing to the remarkable environmental resilience of V. vulnificus.

These adaptive functions highlight how TorA contributes to the ecological success of V. vulnificus across diverse environments. This metabolic flexibility may partially explain why V. vulnificus is such a successful pathogen, capable of rapid growth in human tissues despite transitioning from marine environments. Understanding these adaptations could reveal potential vulnerabilities for therapeutic targeting.

What are the most promising approaches for targeting TorA as a potential vulnerability in Vibrio vulnificus infections?

The unique properties and functions of TorA present several potential avenues for therapeutic intervention against Vibrio vulnificus infections:

1. Structure-Based Inhibitor Design:

  • Determining the crystal structure of V. vulnificus TorA would enable rational design of specific inhibitors

  • Focus on molybdenum coordination sphere for high-specificity inhibitors

  • Virtual screening approaches using homology models based on related TMAO reductases

  • Development of transition-state analogs that bind with high affinity to the active site

2. Regulatory Pathway Disruption:

  • Small molecules that interfere with TorS sensing capabilities

  • Compounds disrupting TorR-DNA binding interactions

  • Peptide inhibitors of TorR dimerization or TorS-TorR interaction

  • CRISPR-Cas delivery systems targeting torRS regulatory elements

3. Metabolic Intervention Strategies:

  • TMAO analogs that compete for binding but resist reduction

  • Compounds that sequester or degrade TMAO in infection sites

  • Alternative electron acceptors that divert electron flow from TorA

  • Molybdenum cofactor biosynthesis inhibitors for broader metabolic impact

4. Combination Approaches:

  • TorA inhibitors combined with conventional antibiotics to prevent anaerobic adaptation

  • Multi-target strategies addressing both TorA and other anaerobic respiratory enzymes

  • Adjuvants that enhance oxygen tension in infected tissues to reduce reliance on TorA

  • Immunomodulatory approaches combined with metabolic inhibitors

Priority Research Areas:

  • Validation of TorA's contribution to virulence through animal infection models

  • High-throughput screening for inhibitors using recombinant TorA

  • Structure determination of V. vulnificus TorA with and without substrates

  • Examination of cross-resistance between TorA inhibition and conventional antibiotics

These approaches would need to address several challenges, including specificity (to avoid targeting human enzymes), delivery to infection sites, and potential redundancy in anaerobic respiratory pathways. The most promising near-term approach would likely combine TorA inhibition with conventional antibiotics to prevent metabolic adaptation during treatment.

What technical advances are needed to better characterize the structure-function relationship of Vibrio TorA enzymes?

Several technical advances would significantly enhance our understanding of structure-function relationships in Vibrio TorA enzymes:

1. Advanced Structural Biology Techniques:

  • Cryo-electron microscopy at high resolution to visualize TorA complexes in native-like states

  • Time-resolved X-ray crystallography to capture intermediates during the catalytic cycle

  • Neutron diffraction studies to precisely locate hydrogen atoms at the active site

  • Solid-state NMR to study membrane interactions and dynamics

2. Computational and Simulation Approaches:

3. Advanced Spectroscopic Methods:

  • Extended X-ray absorption fine structure (EXAFS) to characterize molybdenum coordination

  • Electron paramagnetic resonance (EPR) spectroscopy to study intermediate redox states

  • Resonance Raman spectroscopy to examine cofactor-protein interactions

  • Single-molecule FRET to monitor conformational changes during catalysis

4. Genetic and High-Throughput Approaches:

  • Deep mutational scanning to comprehensively map sequence-function relationships

  • CRISPR-based precise genome editing for in vivo structure-function studies

  • Microfluidic screening platforms for rapid activity analysis of variant libraries

  • Directed evolution under pressure conditions to identify adaptation-related residues

5. Integrated Multi-Omics Approaches:

  • Combined proteomics, metabolomics, and transcriptomics under varying pressure conditions

  • Protein interaction mapping to identify TorA binding partners

  • Comparative genomics across pressure-adapted Vibrio species

  • Structural proteomics to examine post-translational modifications

These technical advances would address several key knowledge gaps:

  • The molecular basis for pressure adaptation in Vibrio TorA

  • The complete catalytic mechanism including all intermediate states

  • The structural determinants of substrate specificity

  • The precise nature of TorA interaction with membrane components and electron donors

Progress in these areas would not only enhance our fundamental understanding of TMAO reductases but could also inform biotechnological applications and therapeutic strategies targeting these enzymes.

What are the most effective protocols for generating site-directed mutations in V. vulnificus TorA to study catalytic mechanisms?

Creating targeted mutations in V. vulnificus TorA requires careful consideration of the enzyme's structure, function, and expression. The following comprehensive protocol outlines the most effective approaches:

Target Selection Strategy:

  • Catalytic Residues:

    • Molybdenum-coordinating residues (typically conserved cysteines)

    • Twin-arginine motif in signal peptide (R-R-X-φ-φ)

    • MGD cofactor binding pocket residues

    • Substrate-binding pocket amino acids

  • Functional Domains:

    • Electron transfer sites

    • Interdomain hinge regions

    • Dimerization interfaces

    • Regulatory sites for allosteric control

Mutagenesis Protocols:

  • QuikChange Site-Directed Mutagenesis:

    • Design primers with 25-45 bp with mutation in center

    • Use high-fidelity polymerase (Pfu Ultra or Q5)

    • PCR conditions: 16-18 cycles, 68°C extension

    • DpnI digestion (3 hours, 37°C) to remove template

    • Transform into competent E. coli

  • Gibson Assembly for Multiple Mutations:

    • Design fragments with 20-40 bp overlaps containing mutations

    • PCR amplify fragments with high-fidelity polymerase

    • Assemble fragments using Gibson master mix (50°C, 1 hour)

    • Direct transformation into high-efficiency competent cells

  • Golden Gate Assembly for Combinatorial Mutagenesis:

    • Design construct with Type IIS restriction sites

    • Prepare library of mutation-containing fragments

    • Single-tube reaction with Type IIS enzyme and ligase

    • Cycling between digestion and ligation temperatures

Expression and Purification Considerations:

  • Expression Systems:

    • Use pET system with T7 promoter for high expression

    • Consider co-expression with TorD chaperone

    • Use E. coli strains with intact molybdenum cofactor synthesis pathway

  • Expression Conditions for Mutants:

    • Lower temperature (18-25°C) to enhance proper folding

    • Extended induction periods (16-24 hours)

    • Supplementation with sodium molybdate (1 mM)

    • Anaerobic conditions post-induction

  • Purification Adaptations:

    • Gentler lysis conditions to preserve unstable mutants

    • Include stabilizing agents (glycerol, reducing agents)

    • Consider detergent additives for potential aggregation-prone mutants

Activity Analysis Protocol:

  • Comparative Kinetic Analysis:

    • Determine kcat and Km for each mutant

    • Calculate catalytic efficiency (kcat/Km)

    • Analyze substrate specificity profiles

    • Study pH and temperature dependencies

  • Stability Assessment:

    • Thermal denaturation assays

    • Pressure stability testing

    • Circular dichroism to monitor secondary structure

    • Size exclusion chromatography to detect aggregation

This comprehensive approach allows systematic investigation of structure-function relationships in V. vulnificus TorA and can be adapted based on specific research questions regarding catalytic mechanism, substrate binding, or pressure adaptation.

How can researchers effectively study the interaction between TorA and the TorRS regulatory system in Vibrio vulnificus?

Investigating the complex interactions between TorA and the TorRS regulatory system requires an integrated approach combining genetic, biochemical, and biophysical techniques:

1. Genetic Interrogation Approaches:

  • Promoter-Reporter Assays:

    • Clone torA promoter regions upstream of fluorescent reporters (GFP, mCherry)

    • Measure promoter activity under varying conditions (oxygen levels, TMAO concentration, pressure)

    • Create promoter truncations and site-directed mutations to identify key regulatory elements

    • Compare responses in wild-type vs. ΔtorR or ΔtorS backgrounds

  • Epistasis Analysis:

    • Generate combinatorial mutants (ΔtorA/ΔtorR, ΔtorA/ΔtorS)

    • Construct strains with constitutively active TorR variants

    • Create chimeric regulatory systems with components from related species

    • Perform complementation studies with mutated regulatory components

2. Biochemical Interaction Studies:

  • TorS-TorR Phosphotransfer:

    • Express and purify recombinant TorS sensor domain and TorR

    • Perform in vitro phosphorylation assays using [γ-32P]ATP

    • Monitor phosphotransfer kinetics under varying conditions

    • Test effects of TMAO, pressure, and other potential signals

  • TorR-DNA Interactions:

    • Perform electrophoretic mobility shift assays (EMSA) with purified TorR and torA promoter fragments

    • Use DNase I footprinting to identify precise binding sites

    • Employ fluorescence anisotropy to measure binding affinities

    • Assess effects of TorR phosphorylation on DNA binding

3. Advanced Biophysical Techniques:

  • Protein-Protein Interaction Analysis:

    • Bacterial two-hybrid assays to detect TorS-TorR interactions

    • Surface plasmon resonance to measure binding kinetics

    • Isothermal titration calorimetry for thermodynamic parameters

    • Co-immunoprecipitation from native Vibrio extracts

  • Structural Studies:

    • X-ray crystallography of TorR DNA-binding domain with target sequences

    • Cryo-EM of full TorRS complex

    • Hydrogen-deuterium exchange mass spectrometry to identify interaction surfaces

    • Small-angle X-ray scattering to determine complex architecture

4. Systems-Level Approaches:

  • Global Transcriptome Analysis:

    • RNA-Seq comparing wild-type, ΔtorR, and ΔtorS under various conditions

    • ChIP-Seq to identify all TorR binding sites genome-wide

    • Time-course experiments to capture dynamic regulatory responses

    • Integration with proteomics data to understand post-transcriptional effects

  • High-Pressure Transcriptomics:

    • Custom pressure vessels for bacterial culture under defined pressure

    • RNA extraction protocols optimized for pressure-treated samples

    • Differential expression analysis comparing ambient vs. high-pressure conditions

    • Validation of key findings with qRT-PCR and reporter assays

Experimental Design Example:
To study pressure-responsive regulation:

  • Culture V. vulnificus strains (WT, ΔtorR, ΔtorS) in custom pressure vessels at various pressures (1-500 atm)

  • Extract RNA and perform RNA-Seq to identify pressure-responsive genes

  • Use promoter-GFP fusions to validate pressure response of torA promoter

  • Purify TorS sensor domain and perform in vitro binding assays with potential signals

  • Use site-directed mutagenesis to identify pressure-sensing residues in TorS

This multi-faceted approach would provide comprehensive insights into how the TorRS system regulates torA expression in response to environmental signals, particularly the unique pressure-responsive regulation observed in Vibrio species .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.